HCW Biologics Files Q1 2025 10-Q, Reports Subsequent Events
Ticker: HCWB · Form: 10-Q · Filed: May 15, 2025 · CIK: 1828673
Sentiment: neutral
Topics: 10-Q, subsequent-event, biotech
TL;DR
HCW Biologics Q1 2025 10-Q filed. Secured debt update & CEO/Chairman news post-period.
AI Summary
HCW Biologics Inc. filed its Q1 2025 10-Q report on May 15, 2025, detailing operations for the period ending March 31, 2025. The company's business address is 2929 N Commerce Pkwy, Miramar, FL 33025. Key events include a subsequent event on May 1, 2025, related to secured debt, and another on May 5, 2025, involving Founder and CEO Hing C. Wong and Board of Directors Chairman Scott T. Garrett.
Why It Matters
This filing provides investors with an update on HCW Biologics' financial health and operational activities for the first quarter of 2025, including significant post-period events.
Risk Assessment
Risk Level: medium — The filing details financial performance and operational updates, which can carry inherent risks for investors.
Key Numbers
- Q1 2025 — Reporting Period (First quarter financial and operational data)
Key Players & Entities
- HCW Biologics Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250515 (date) — Filing date
- 2929 N Commerce Pkwy, Miramar, FL 33025 (address) — Company business address
- 2025-05-01 (date) — Subsequent event date (secured debt)
- 2025-05-05 (date) — Subsequent event date (CEO/Chairman)
- Hing C. Wong (person) — Founder and CEO
- Scott T. Garrett (person) — Board of Directors Chairman
FAQ
What were the key financial results for HCW Biologics in Q1 2025?
The provided text does not contain specific financial figures for Q1 2025, only the reporting period dates.
What specific 'secured debt' event occurred on May 1, 2025?
The filing mentions a subsequent event related to 'us-gaap:SecuredDebtMember' on May 1, 2025, but does not provide details of the event itself.
What is the significance of the May 5, 2025 subsequent event involving the CEO and Chairman?
The filing notes a subsequent event on May 5, 2025, involving Founder and CEO Hing C. Wong and Board of Directors Chairman Scott T. Garrett, but the specific nature of the event is not detailed in the provided text.
What is HCW Biologics' Standard Industrial Classification (SIC) code?
HCW Biologics Inc. has a Standard Industrial Classification code of 2834, which corresponds to Pharmaceutical Preparations.
When was HCW Biologics Inc. incorporated and what is its fiscal year end?
HCW Biologics Inc. was incorporated in Delaware (DE) and its fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 by Hing C. Wong regarding HCW Biologics Inc. (HCWB).